Search Results 201-210 of 16906 for Alexithymia
Publications · Khoja IT, Peck DS, Gavrilov DK, McPheron MA, Oglesbee D, Bentz Pino G, Sapp KL, Schultz MJ, Studinski Jones AL, White AL, Tortorelli S, Matern D, ...
The goal of this proposed study is to examine the genetic signature of the validated proteomic signature (model) based on a panel of serum proteomic markers ...
The purpose of the ISCHEMIA trial is to determine the best management strategy for higher-risk patients with stable ischemic heart disease. This is a ...
Feel more alert and aggressive. Common stimulants include caffeine and drugs called amphetamines. Cold medicines often have a stimulant in them. Energy drinks ...
About this study. To determine the effectiveness of the ARTISAN Aphakia lens in the treatment of aphakia and to precisely define the associated risks and, ...
Healthcare professionals and researchers in ear, nose and throat (ENT) conditions and brain and nervous system conditions (neurology) study voice disorders and ...
Understand more about this brain disease that is the most common cause of dementia. Also learn about new tests and medicines.
Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...
Find out more about this type of dementia that affects the speech and language areas of the brain.
This randomized phase III trial compares memantine hydrochloride and whole-brain radiotherapy with or without hippocampal avoidance in reducing ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your gift to celebrate this day advances our doctors’ lifesaving work.